Skip to main content

Table 7 The psychometric properties of assessment tools used in patients with a diagnosis of brain tumor

From: Comparison of content and psychometric properties for assessment tools used for brain tumor patients: a scoping review

Assessment instrument

Reliability

Validity

Responsiveness

Time

Research group

References

Test–retest

Inter-rater

Intra-rater

Content

Structural

Criterion

EORTC QLQ-BN20

  

+

 

+

 

+

 

n = 891, brain tumor

Taphoornet al. [27]

  

+*

 

+

  

< 10 min

n = 350, glioma, meningioma

Shin and Kim [28]

  

+

 

+

 

+

 

n = 194, brain tumor

Khoshnevisan et al. [29]

  

+

 

+

   

n = 100, brain tumor

Bunevičius et al. [30]

EORTC QLQ-C30

  

+*

  

+

13–14 (SD 12) min

n = 366, brain tumor

Cheng et al. [31]

FACT-Br

+

 

+

 

+

   

n = 500, brain tumor

Arli and Gurkan [32]

+§

 

+†,‡

 

+

  

5 to 10 min

n = 101, brain tumor

Weitzner et al. [33]

+

   

+

 

+

 

n = 62, metastases in the brain

Thavarajah et al. [34]

SF-36

  

+

 

+

  

10 [40,41,42,43,44,45] min

n = 277, brain tumor

Bunevičius et al. [30]

  1. For interpretation of “+” and “−” for each property: Internal reliability: “+” Cronbach’s ɑ or ICC ≥ 0.70; “−” Cronbach’s ɑ or ICC < 0.70;
  2. Test/retest method: “+” ICC ≥ 0.70 or Pearson correlation coefficient/ Spearman rank correlation coefficient ≥ 0.80; “−” ICC < 0.70 or Pearson correlation coefficient/Spearman rank correlation coefficient < 0.80;
  3. Interrater reliability: “+” ICC ≥ 0.70 or Pearson correlation coefficient/ Spearman rank correlation coefficient ≥ 0.80; “−” ICC < 0.70 or Pearson correlation coefficient/Spearman rank correlation coefficient < 0.80;
  4. Content validity: “+” The content of the assessment instrument is adequate, comprehensive, questions and tasks chosen to adequately reflect the content to be evaluated; “ –” Not all selected questions and tasks reflect the content, content is not relevant, comprehensive;
  5. Criterion validity: “+” Significant and stable relation between measurement and another instrument (r ≥ 0.70) or with start/end measurement; “ –” Poor measurement correlation with another instrument (r < 0.70) or start/end measurement;
  6. Structural validity: “+” Correlation with instruments measuring the same ≥ 0.50 or correlation higher for unrelated elements in the instrument than for unrelated ones; “−” Correlation with instruments measuring the same < 0.50 or correlation with related elements in the instrument is lower than unrelated ones;
  7. Responsiveness: “+” Able to detect clinically significant changes over time; “−” Cannot detect clinically significant changes over time
  8. SD, standard deviation
  9. *Except Cognitive scale; Except Social, family wellbeing domains; Except Interaction with a physician domain; §Functional Assessment of Cancer Therapy—General questionnaire analyzed